CA2525285A1 - Protective coatings for dilation balloons - Google Patents

Protective coatings for dilation balloons Download PDF

Info

Publication number
CA2525285A1
CA2525285A1 CA002525285A CA2525285A CA2525285A1 CA 2525285 A1 CA2525285 A1 CA 2525285A1 CA 002525285 A CA002525285 A CA 002525285A CA 2525285 A CA2525285 A CA 2525285A CA 2525285 A1 CA2525285 A1 CA 2525285A1
Authority
CA
Canada
Prior art keywords
balloon
plasma polymerized
polymerized layer
monomer
layer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002525285A
Other languages
French (fr)
Inventor
Nie Tang
Daniel Horn
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boston Scientific Ltd Barbados
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2525285A1 publication Critical patent/CA2525285A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L29/00Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
    • A61L29/08Materials for coatings
    • A61L29/085Macromolecular materials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00Catheters; Hollow probes
    • A61M25/10Balloon catheters
    • A61M25/1027Making of balloon catheters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00Catheters; Hollow probes
    • A61M25/10Balloon catheters
    • A61M25/1027Making of balloon catheters
    • A61M25/1029Production methods of the balloon members, e.g. blow-moulding, extruding, deposition or by wrapping a plurality of layers of balloon material around a mandril
    • A61M2025/1031Surface processing of balloon members, e.g. coating or deposition; Mounting additional parts onto the balloon member's surface
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00Catheters; Hollow probes
    • A61M25/10Balloon catheters
    • A61M2025/1043Balloon catheters with special features or adapted for special applications
    • A61M2025/1075Balloon catheters with special features or adapted for special applications having a balloon composed of several layers, e.g. by coating or embedding

Abstract

A dilatation balloon formed of a first material and further including at least one first plasma polymerized layer which forms the top most surface of the balloon, and a method of making the same.

Description

PROTECTIVE COATINGS FOR MEDICAL DEVICES
FIELD OF THE INVENTION
The present invention relates to coatings for medical devices and to methods of making and using the same.
BACKGROUND OF THE INVENTION
Balloon catheters are well-known devices in which the catheter carries an inflatable balloon to occlude and.seal a body space, to expand a blood vessel through pressurized inflation of the balloon, or for any other desired purpose which may typically but not necessarily be a therapeutic purpose in the medical field.
In the case of dilatation balloon catheters for angioplasty, for example a PTCA procedure, the catheter balloon is commonly made out of a thin, strong material which is of relatively low resilience. Examples of materials from which a catheter balloon may be made include biaxially oriented polyethylene terephthalate (PET) copolymers, a polyamide material such as nylon or polyether-block-amide copolymers to mention only a few. These materials are typically strong, flexible materials and have the advantage that they are flexible but inelastic so that they can expand outwardly to a predetermined diameter, and then cease further expansion at normal pressures, to avoid damage to the artery wall by over expansion.
The fact that balloon angioplasty requires extremely thin walled material, high strength (i.e. high tensile), relatively inelastic material of predictable inflation properties, leads to a common problem which is that the balloons can be easily punctured through abrasion or the like, even though they have a high tensile strength.
Pin holes and ruptures are a fairly common problem when such catheter balloons are used in contact with rough surfaces. Also, tiny flaws in the mold of such balloons can create wealc spots, since the balloons are so thin-walled. However, it is impractical to increase the wall thickness of these balloons because then they become too stiff, with high flexural moduli, with the result that such balloons do not collapse properly on deflation to facilitate easy withdrawal from the vascular system of a patient.
Further, thin walls are necessary because the balloon's wall and waist thicknesses limit the minimum diameter of the distal end of the catheter and therefore determine the limits on vessel size treatable by the method and the ease of passage of the catheter through the vascular system. High strength is necessary because the balloon is used to push open a stenosis and so the thin wall must not burst under the high internal pressures necessary to accomplish this task. The balloon must have some elasticity so that the inflated diameter can be controlled, so as to allow the surgeon to vary the balloon's diameter as required to treat individual lesions, but that elasticity must be relatively low so that the diameter is easily controllable. Small variations in pressure must not cause wide variation in diameter.
The high strength biaxi~lly oriented polyethylene terephthalate (PET) or polyamides such as nylon or the polyamide copolymers tend to be less elastic, and have less resilience. Balloon catheters may be made of more elastic materials such as polyolefins or polyolefin copolymers, but typically, in order to achieve the high tensile strength, the balloon walls must be made thicker.
Coatings may be used to modify the surface of the balloon to improve abrasion and puncture resistance, but such coatings typically increase the wall thickness, and decrease the flexibility and thus increase the stiffness and flexural moduli of the balloon. This increased stiffness and increased flexural moduli can result in balloons which do not collapse properly on deflation to facilitate easy withdrawal from the vascular system of a patient.
Coatings may be used for other purposes such as increasing lubricity as well and for delivering therapeutic agent(s), for example. Typically, such coatings are provided by dipping, brushing, painting, and so forth.
US Patent No. 6,287, 277 describes balloons formed by a vacuum deposition process.
US Patent No. 5,451,428 describes a plasma polymerizing an intermediate layer onto a medical device which is then used to react with a biocompatible coating to provide optimum adhesion of the biological coating.
There remains a need for materials and methods which can provide improved balloon catheters which are thin walled, yet have a durable, abrasion and tear resistant surface thereby improving the resistance to pinhole formation, and yet are relatively flexible, yet inelastic to allow the balloons to expand outwardly to a predetermined diameter, and then cease further expansion at normal pressures, to avoid damage to the artery wall by overexpansion.
SUMMARY OF THE INVENTION
In one aspect, the present invention relates to implantable medical devices having proximal and distal ends adapted for manipulation outside of the body.
The device includes an elongate body extending between the proximal and distal ends and a polymeric expandable portion located at the distal end of the elongate body. The expandable portion further includes at least one first plasma polymerized layer which forms the outer most layer of the expandable portion. The expandable portion may be a dilatation balloon, such as those used for angioplasty. In some embodiments, more than one plasma polymerized layer is employed.
The plasma polymerized layers) is formed through the use of monomers in gaseous form and which when exposed to a source of electromagnetic radiation which irradiates high frequency waves, undergo plasma polymerization. The "plasma"
is a partially ionized gas in which highly reactive free radicals and/or ions are present. The gaseous monomers condense and crosslink on the surface of the medical device.
The crosslinlc density can be controlled by the amount of monomer supplied, as well as the conditions under which the plasma polymerization is conducted.
The present invention finds utility for providing a protective layer on the surface of a balloon.
The present invention has found that certain plasma polymerized coatings provide improved abrasion resistance.
The present invention further relates to a method of coating the surface of a catheter balloon with an abrasion resistant coating. The method includes the steps of exposing the balloon to at least one first gaseous monomer composition and exposing the gaseous monomer to electromagnetic waves to form a plasma. The monomers condense on the surface of the catheter balloon and crosslink to form at least one first plasma polymerized layer on the surface of the balloon. The first plasma polymerized layer forms the outermost layer of the catheter balloon.
A second plasma polymerized layer can also be applied to the surface of the balloon in the same manner. The second layer is applied between the first plasma polymerized layer and the catheter balloon. In one embodiment, the second layer is an abrasion resistant coating, and the first plasma polymerized layer is a softer coating.
BRIEF DESCRIPTION OF THE DRAWINGS
Fig. 1 is a cross sectional view of a balloon having at least one plasma polymerized layer according to the present invention.
Fig. 2 is a cross sectional view of a balloon according to the present invention which has more than one plasma polymerized layer.
Fig. 3 is a side view of a balloon according to the present invention which has at least one plasma polymerized layer in combination with a catheter device.
Fig. 4 is a side view of a balloon according to the present invention which has more than one plasma polymerized layer in combination with a stent.
DETAILED DESCRIPTIONS OF THE PREFERRED EMBODIMENTS
While this invention may be embodied in many different forms, there are described in detail herein specific embodiments of the invention. This description is an exemplification of the principles of the invention and is not intended to limit the invention to the particular embodiments illustrated.
Turning first to the figures, Fig, 1 illustrates generally at 10, a dilatation balloon according to the invention shown in an inflated state. It should be noted that in each of the following figures, lines and dimensions are not shown to scale.
Such figures are for illustrative purposes only. Balloon 10 has a body 24, cones 26 and waist portions 22. In this particular embodiment, proximal end 28 of balloon 10 is shown secured by adhesively bonding, welding or some such method to the distal outer tube 12 and the distal end 29 of balloon 10 is shown secured to the distal end of inner tube 13. The balloon in this embodiment is shov~m with a single plasma polymerized layer 15 of a material which improves abrasion and puncture resistance of the balloon.
One of ordinary skill in the art would understand that there are numerous other balloon configurations and that the present invention is not limited to any one particular configuration. These figures are for illustrative purposes only.
Fig. 2 is a cross sectional view of the same type of balloon structure as shown in Fig. 1. However, in this embodiment, balloon 10 is further shown with a second plasma polymerized layer 17 located between the balloon 10 and the first plasma polymerized layer 15. In this embodiment, the second plasma polymerized layer 17 is such that it provides the balloon with abrasion and puncture resistance and the first outer plasma polymerized layer 15 is such as to provide a better surface for the stent to grip.
Thus, the first outer plasma polymerized layer 15 is relatively softer than the second intermediate plasma polymerized layer 17.
Fig. 3 illustrates a balloon catheter 20 according to the present invention having an elongated flexible shaft 12 and an inflatable balloon 10. Catheter 20 has a proximal end 30 and a distal end 32. Inflatable balloon 10 is mounted at the distal end 32 of the elongated flexible shaft 12. Except as noted herein, catheter 20 is conventional in its construction, providing a lumen communicating with the interior of balloon 10, for inflation and deflation of the balloon, and other optional features conventional in the dilatation catheter art. The balloon 10 is shown in an inflated configuration and has a body 24, cones 26 and waist portions 22. The balloon is shown with a single plasma polymerized layer 15 on the body 24, cones 26 and waist portions 22. Balloon may optionally have more plasma polymerized layers as well. In this embodiment, the single plasma polymerized layer provides a hard abrasion resistant coating. During a medical procedure, proximal end 30 remains outside of the patient's body and typically has a means for manipulating the distal end 32 of the device from outside of the body (not shown).
Fig. 4 is a cross sectional view of the same balloon shown in Fig. 3 in combination with a stmt 40.
The coatings according to the present invention are applied to the balloon using a technique known as plasma polymerization. The balloon on which the plasma is to be deposited is placed in a plasma deposition chamber with a vacuum.
Suitably, the deposition chamber is pressure tight, and a pressure below atmospheric is applied such that the chamber substantially forms a vacuum within. Typical pressures are between about 10-5 bar to 10-a bar. Chambers for plasma polymerization are known in the art.
Monomers in gaseous form are then conducted into the chamber. A source of energy, i.e. electromagnetic radiation irradiates high-frequency waves into the chamber, thereby creating a plasma.
Plasma polymerization is initiated through the use of a non-equilibrium ionized gas plasma. The "plasma" is a partially ionized gas in which free radicals and/or ions are present. Whereas a free radical is a highly reactive chemical species carrying no charge and having a single unpaired electron in an orbital, a cation is a positively charged ion or an atom or group of atoms that has lost one or more electrons and an anion is a negatively charged ion or an atom or group of atoms that has gained one or more electrons.
The majority of polymerization, however, is completed in the absence of the plasma. Gaseous monomers condense on the article, i.e. the balloon, as highly cross-linked layers. In this manner, a high molecular weight polymer may be formed.
The formation of the ionized gas plasma may be accomplished by any of the techniques known to produce such plasmas. For example, see J. R. Hollahan and A.
T. Bell, eds., "Techniques in Applications of Plasma Chemistry", Wiley, New York, 1974 and M Shen, ed: "Plasma Chemistry of Polymers", Marcel Dekker, New York, 1976. For example, using one method, an ionizable gas is contained under vacuum between parallel plate electrodes connected to a radio frequency generator.
The plasma can be created with parallel plates that are either external or internal to the plasma deposition chamber. Other methods include use of an external induction coil to create an electric field which produces the plasma of ionized gas, or use of oppositely charged electrode points placed directly into the plasma vacuum chamber in spaced apart relationship to create the plasma. See also US Patent 6,462,012, the entire content of which is incorporated by reference herein.
The present inventors have found that the amount of crosslinking density can be controlled, and thus the physical properties of the plasma polymerized layer by altering plasma process conditions such as power, vacuum and flow rate, as well as the type of monomers used in the process. In this manner, the hardness of the coating can be manipulated to achieve improvements in balloon durability as well as stem retention.
For example, a harder coating with improved durability may be obtained by higher power input and lower flow rate, and a soften coating for better stmt retention may be obtained by lower power and higher flow rate.
Another technique which may be employed to obtain a softer outer layer is through the use of plasma enhanced polymerization. Using this technique, conventional polymerization reactions are initiated and propagated and polymers with structures similar to those of the monomer can be obtained.
W one embodiment, a mufti-layered balloon is obtained having a mid-layer with a harder coating for improved durability, with an outer layer which is softer for better stmt retention.
Stent securement is a key consideration. Balloons having a thin-walled, small diameter design, typically have a thinner wall thickness and increased risk of burst failure. The plasma polymerized layer with high crosslink density can provide a strong, durable coating, without dramatically increasing the wall thiclmess and balloon diameter.
To apply the polymer coating, the medical device is put in a closed, preferably pressure-tight chamber. Any chamber used for such reactions can be employed in the present invention. The chamber may be of any configuration including, for example, bell shaped, cubic, rectangular, or any other shape typical to vacuum chambers. The chamber can also be formed of a variety of materials including, for example, steel, glass, polymers, ceramic or composites.
The monomers in gas form are streamed through a valve or other appropriate opening, into the deposition chamber. A source or radiant energy is applied to the chamber. Any suitable configuration for application of the energy to the chamber may be employed. Electromagnetic waves irradiated into the chamber and the spark discharge causes the gas to form a plasma which is a gas having free radicals or ions, i.e.
anions or canons. Frequencies which may be employed include, for example, alternating current (AC) of about 50-60 Hz, radio frequency (RF) of about 13:56 MHz or microwave frequency of about 2.45 GHz.
The method according to the present invention allows a very thin plasma polynerized film to be laid down on the surface of the balloon, thereby keeping the increase in wall thickness of the balloon to a minimum. In fact, plasma polymerization as employed herein can be used to form a layer of high crosslink density which is similar to a monolayer, being as little as about 100-2000 A thick, more typically about 300-2000 A, and even more suitably about 1000-2000 A.
The method according to the present invention can also be employed to put down multiple layers having different properties such as those going from hard to soft. The hardness/softness of the plasma polymerized layer can be controlled by the amount of polymerization or crosslinlc density. This in turn is controlled by the type of monomer, and the power, vacuum and flow rate employed in the process.
Any monomer capable of forming a plasma which has free radicals and/or ions, i.e. cations or anions, when subjected to electromagnetic radiation may be employed herein. More specifically, examples of monomers useful in forming the plasma polymerized layer as described herein include, but are not limited to hydrocarbons, nitrogen containing compounds, fluorine containing monomers, silicon containing monomers, oxygen containing monomers, and mixtures thereof.
Some examples of suitable hydrocarbons includes those having reactive double bonds and triple bonds, aromatic compounds, and so forth.
More specific examples of suitable hydrocarbons include, but are not limited to, methane, ethylene, propylene, butadiene, benzene, xylene, toluene, mixtures thereof, and so forth.
Examples of suitable nitrogen containing compounds include the amines and the nitriles. Examples of suitable amines include, for example, pyrrole, a cyclic, secondary amine structure.
Examples of suitable fluorocarbons include, but are not limited to, fluoroalkyls, perfluoroalkyls such as perfluoropropane and perfluoroalkenes such as perfluorobutene, fluorohydroalkyls, cyclofluoroalkyls, fluorobenzene, and so forth. The advantage of employing fluorocarbons is that the lubricity of the balloon surface as well as abrasion and puncture resistance, can also be increased. Use of fluorinated monomers for plasma polymerization are described in US 6495624 which is incorporated by reference herein in its entirety.
Examples of suitable oxygen containing compounds include, but are not limited to, ethers, esters and acids.
Examples of suitable silicon containing compounds include silanes, siloxanes, silazenes, and so on and so f~rth. Specific examples of suitable silanes include, but are not limited to, dimethylsilane, trimethylsilane, aminopropyltriethoxysilane, and so forth.
Specific examples of suitable siloxanes include, but are not limited to, dimethylsiloxane, trimethylsiloxane, and so forth.
Members of the titanate family may also be employed in the plasma polymerization process described herein.
Monomers having ethylenic unsaturation such as vinyl monomers, may also be employed in the present invention. Examples of,monomers having ethylenic unsaturation include, but are not limited to, N-vinylpyrrolidone (NVP), hydroxyethylinethacrylate (HEMA), vinyl substituted polyethers such as vinyl-polyethylene glycol (VPEG) or vinyl-polypropylene glycol (VPPG), acrylamide (AM), dimethylacrylamide (DMA), hydroxy-propylacrylates, and so forth.
Of course, mixtures of any of the above materials may also be employed.
The balloon may be formed from any suitable material known in the art.
Examples of suitable balloon materials include, but are not limited to, polyesters and copolymers thereof such as polyethylene and copolymers thereof, polyesters and copolymers thereof such as polyethylene terephthalate (PET), polyamides such as nylon and SELAR~ and copolymers thereof such as polyether-block-amides (PEBAX~), elastomeric polyesters and copolymers thereof such as HYTREL~ polyetherester, and so forth.
The balloon is placed in a high pressure deposition chamber, the appropriate monomers in gaseous form are conducted into the chamber, and the chamber is then exposed to electromagnetic radiation. The source of the electromagnetic ratio may be direct current, alternating current, microwave, radio-frequency plasma, electron beam, gamma radiation, and so forth. The monomers condense and crosslink on the surface of the balloon. The amount of deposition as well as the crosslinlc density, can be controlled by deposition time, sample location, power, and flow rate.
The resultant crosslinked plasma coating has excellent adhesion to the balloon surface, and provide a thin, very strong, chemically resistant permanent coating.
The coating can be advantageously used to increase the surface hardness of the balloon, thereby improving abrasion resistance, and decreases pinhole formation, leakages and ruptures.
Because the coating can be deposited as a very think layer, i.e. about 1000-20001, it has no negative impact on balloon profile.
The following non-limiting examples further illustrate embodiments of the present invention.

EXAMPLES
TEST METHODS
1. Abrasion Testing Balloon ends were attached to a fixture which can slide back and forth. The center portion of the balloons were located such that it rested on top of a diamond tipped file. The balloons were inflated to 88 psi (about 91 kg/cma). A load was selected and placed on the balloons which can be varied between 1 and 2000 grams. The balloons - were dragged across-the file surface and-observed for bursting or leaking.
Example 1 The effects of the plasma coatings on balloon performance was evaluated using abrasion testing.
Coated balloons were compared to non-coated (control) balloons. The monomer employed was pyrrole. The base control balloons employed had a diameter of 3.0 mm and are described in the following table 1.
Table 1 Control Material 2x Wall Thickness2x Wall Thickness (in) Balloon Std. Dev.

A PEBAX 7233 0.00122 3.162E-05 (0.00309 cm) B PEBAX 7233 0.00109 1.789E-05 (0.00276 cm) The balloons were coated using five different plasma coating conditions.
The groups each included both A balloons coated with a plasma polymerized layer and B
balloons coated with a plasma polymerized layer described in Table 1 above.
The conditions employed for each group are shown in the following Table 2.

Table 2 IdentifierBalloon Monomer CoatingPre- Power Coating Time cleaning(W)/ Successful?

Pressure (mTorr) Group B Pyrrole 3 min 10 min 80/150 Yes Argon Group B - - Pyrrole 5 min 10 min 80/275 Yes, but 2 not Argon uniform Group A Pyrrole 1 min 5 min 80/250 Yes Oxygen Group A Pyrrole 3 min 5 min 60/250 Yes Oxygen Group A Pyrrole 5 min 5 min 60/250 Yes Oxygen A none - - - -B none - - - -After plasma coating, the balloons were subjected to abrasion testing 5 with the results shown in the following Table 3.

Table 3- Abrasion Test Summary IdentifierLoad (g) Result Total No. TestedFailed Did not Fail Group 200 5 5 0 Group 200 7 3 4 Group 250 7 5 2 Group - 250 7 3 4 Group 250 7 0 7 Group 300 1 0 1 Group 400 1 0 1 Group 500 1 1 0 Both balloon bursts as well as leaks were indicated as a failure. The load was increased many times for the group 5 samples to fmd out the point at which failures 5 would occur. Additional samples were also tested for the A group and the B
group in order to discover at which load these balloons exhibited failures. An inspection of the group 2 balloons showed that the coating was non-uniform indicating why some samples failed while others in the group did not.

The above disclosure is intended to be illustrative and not exhaustive.
The description will suggest many variations and alternatives to those of ordinary skill in the art. All of these alternatives and variations are intended to be included within the scope of the attached claims. Those familiar with the art may recognize other equivalents to the specific embodiments described herein which equivalents are also intended to be encompassed by the claims attached hereto.

Claims (21)

1. A dilatation balloon formed from a first material and further comprising at least one first plasma polymerized layer which forms the outer most layer of said balloon.
2. The balloon of claim 1 wherein said plasma polymerized layer is formed by the reaction of a monomer selected from the group consisting of hydrocarbons, amines, nitriles, fluorocarbons, silanes, siloxanes, silazenes, titanates, ethers, esters, acids, alcohols and mixtures thereof.
3. The balloon of claim 1 wherein said at least one plasma polymerized layer is formed using at least one organic monomer.
4. The balloon of claim 2 wherein said hydrocarbon is methane, polyethylene, polypropylene, butadiene, benzene, toluene, xylene and mixtures thereof.
5. The balloon of claim 1 wherein said at least one plasma polymerized layer is formed by at least one pyrrole monomer.
6. The balloon of claim 1 wherein said monomer is a fluorocarbon selected from the group consisting of fluoroalkyls, fluorohydroalkyls, cyclofluoroalkyls, fluorobenzene and mixtures thereof.
7. The balloon of claim 1 further comprising a second plasma polymerized layer which is between said balloon and said at least one first plasma polymerized layer.
8. The balloon of claim 7 wherein said second plasma polymerized layer is harder than said at least one first plasma polymerized layer.
9. An implantable medical device having proximal and distal ends adapted for manipulation outside of the body said device comprising:
a polymeric elongate body extending between proximal and distal ends of said device; and a polymeric expandable portion located at said distal end of said elongate body;
wherein said expandable portion comprising at least one first plasma polymerized layer which forms the outer most layer of the balloon.
10. The medical device of claim 9 wherein said expandable portion is a dilatation balloon.
11. The medical device of claim 10 wherein said balloon is a multilayer balloon comprising at least one second plasma polymerized layer which forms an intermediate layer between said balloon and said first plasma polymerized layer, said first plasma polymerized layer is softer than said second plasma polymerized layer.
12. The medical device of claim 11 wherein said intermediate layer is formed through the reaction of pyrrole monomer.
13. The medical device of claim 10 further comprising a stent disposed about said dilatation balloon.
14. A method of coating the surface of a catheter balloon with an abrasion resistant coating said method comprising the steps of:
(a) exposing said balloon to at least one first gaseous monomer composition;
and (b) exposing said gaseous monomer to electromagnetic waves to form a plasma said monomers condensing on said catheter balloon and crosslinking to form at least one first plasma polymerized layer, and wherein said at least one first plasma polymerized layer forms the outermost layer of said catheter balloon.
15. The method of claim 14 wherein said monomer is selected from the group consisting of hydrocarbon monomers, silicon containing monomers, fluorocarbon monomers, ethylenically unsaturated monomers, titanates, and mixtures thereof.
16. The method of claim 15 wherein said monomer is a hydrocarbon monomer selected from the group consisting of benzene, toluene, xylene, methane, ethylene, propylene, butadiene and mixtures thereof.
17. The method of claim 15 wherein said monomer is a fluorocarbon selected from the group consisting of fluoroalkyls, fluorohydroalkyls, cyclofluoroalkyls, fluorobenzene and mixtures thereof.
18. The method of claim 14 wherein said monomer is pyrrole.
19. The method of claim 14 wherein said monomer is an organic monomer.
20. The method of claim 14 further comprising the steps of:
c) exposing said balloon to at least one second gaseous monomer composition; and d) exposing said at least one second gaseous monomer composition to electromagnetic waves to form a plasma said monomers condensing on said catheter balloon and crosslinking to form at least one first plasma polymerized layer, and wherein steps c) and d) occur before steps a) and b) and wherein said at least one first plasma polymerized layer forms the outermost layer of said catheter balloon.
21. The method of claim 20 wherein said second plasma polymerized layer is harder than said first plasma polymerized layer.
CA002525285A 2003-07-18 2004-05-27 Protective coatings for dilation balloons Abandoned CA2525285A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10/622,624 US7335185B2 (en) 2003-07-18 2003-07-18 Protective coatings for medical devices
US10/622,624 2003-07-18
PCT/US2004/016777 WO2005014075A1 (en) 2003-07-18 2004-05-27 Protective coatings for medical devices

Publications (1)

Publication Number Publication Date
CA2525285A1 true CA2525285A1 (en) 2005-02-17

Family

ID=34063237

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002525285A Abandoned CA2525285A1 (en) 2003-07-18 2004-05-27 Protective coatings for dilation balloons

Country Status (5)

Country Link
US (1) US7335185B2 (en)
EP (1) EP1648535B1 (en)
JP (1) JP4740843B2 (en)
CA (1) CA2525285A1 (en)
WO (1) WO2005014075A1 (en)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6863678B2 (en) 2001-09-19 2005-03-08 Advanced Cardiovascular Systems, Inc. Catheter with a multilayered shaft section having a polyimide layer
JP2003175110A (en) * 2001-12-07 2003-06-24 Kanegafuchi Chem Ind Co Ltd Balloon catheter and method for manufacturing the same
EP1861152B1 (en) * 2005-02-28 2018-09-12 Tracoe medical GmbH Inhaled air supplying device
US9125968B2 (en) * 2005-03-30 2015-09-08 Boston Scientific Scimed, Inc. Polymeric/ceramic composite materials for use in medical devices
US20070010596A1 (en) * 2005-07-08 2007-01-11 Georgia Tech Research Corporation Plasma-Polymerized Hydrogel Thin Films and Methods for Making the Same
DK1745807T3 (en) 2005-07-18 2012-11-26 Dentsply Ih Ab Urinary catheter
DE102005034764B4 (en) * 2005-07-26 2012-08-02 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Process for the preparation of functional fluorocarbon polymer layers by plasma polymerization of perfluorocycloalkanes and substrates coated therewith
US7365126B2 (en) * 2005-09-16 2008-04-29 Boston Scientific Scimed, Inc. Medical device articles formed from polymer-inorganic hybrids prepared by ester-alkoxy transesterification reaction during melt processing
US8008395B2 (en) * 2005-09-27 2011-08-30 Boston Scientific Scimed, Inc. Organic-inorganic hybrid particle material and polymer compositions containing same
EP1948750A1 (en) * 2005-11-16 2008-07-30 FUJIFILM Corporation Surface-hydrophilic structure
JP5094081B2 (en) * 2005-11-17 2012-12-12 富士フイルム株式会社 Hydrophilic member and method for producing the same
JP2009519770A (en) * 2005-12-16 2009-05-21 インターフェイス・アソシエイツ・インコーポレーテッド Medical multilayer balloon and method for producing the same
US7828766B2 (en) 2005-12-20 2010-11-09 Advanced Cardiovascular Systems, Inc. Non-compliant multilayered balloon for a catheter
US7906066B2 (en) * 2006-06-30 2011-03-15 Abbott Cardiovascular Systems, Inc. Method of making a balloon catheter shaft having high strength and flexibility
US8382738B2 (en) 2006-06-30 2013-02-26 Abbott Cardiovascular Systems, Inc. Balloon catheter tapered shaft having high strength and flexibility and method of making same
US8926620B2 (en) 2006-08-25 2015-01-06 Kyphon Sarl Apparatus and methods for use of expandable members in surgical applications
US8043362B2 (en) * 2006-08-25 2011-10-25 Kyphon Sarl Apparatus and methods for use of expandable members in surgical applications
US7963942B2 (en) * 2006-09-20 2011-06-21 Boston Scientific Scimed, Inc. Medical balloons with modified surfaces
US8012591B2 (en) * 2006-09-21 2011-09-06 Fujifilm Corporation Hydrophilic composition and hydrophilic member
TR200605770A2 (en) * 2006-10-16 2007-10-22 Ykk Saglik Hizmetleri Anonim Sirketi Flexible and rigid catheter resector balloon
JP2008238711A (en) * 2007-03-28 2008-10-09 Fujifilm Corp Hydrophilic member, and undercoating composition
US20090029179A1 (en) * 2007-05-14 2009-01-29 Fujifilm Corporation Two-liquid composition, hydrophilic composition and hydrophilic member
FR2923494B1 (en) * 2007-11-09 2010-01-15 Hutchinson IMPER-BREATHING MEMBRANES AND METHOD FOR THE PRODUCTION THEREOF
US8403885B2 (en) 2007-12-17 2013-03-26 Abbott Cardiovascular Systems Inc. Catheter having transitioning shaft segments
JP2009227809A (en) * 2008-03-21 2009-10-08 Fujifilm Corp Hydrophilic composition and hydrophilic treating member
WO2009135125A2 (en) 2008-05-01 2009-11-05 Bayer Schering Pharma Ag Catheter balloon drug adherence techniques and methods
EP2151253A1 (en) 2008-07-31 2010-02-10 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Biocompatibility coating and coated objects
US8052638B2 (en) 2008-11-26 2011-11-08 Abbott Cardiovascular Systems, Inc. Robust multi-layer balloon
US8444608B2 (en) 2008-11-26 2013-05-21 Abbott Cardivascular Systems, Inc. Robust catheter tubing
US8070719B2 (en) * 2008-11-26 2011-12-06 Abbott Cardiovascular Systems, Inc. Low compliant catheter tubing
US8703260B2 (en) 2010-09-14 2014-04-22 Abbott Cardiovascular Systems Inc. Catheter balloon and method for forming same
US10406329B2 (en) 2011-05-26 2019-09-10 Abbott Cardiovascular Systems, Inc. Through tip for catheter
US20130046375A1 (en) 2011-08-17 2013-02-21 Meng Chen Plasma modified medical devices and methods
CN104185491B (en) * 2011-12-14 2016-08-10 东莞市迪凯精密管材有限公司 The sacculus dilating catheter that soft cladding is most advanced and sophisticated is set
WO2013106862A1 (en) * 2012-01-13 2013-07-18 Curators Of The University Of Missouri Low temperature plasma coating for anti-biofilm formation
US8684963B2 (en) 2012-07-05 2014-04-01 Abbott Cardiovascular Systems Inc. Catheter with a dual lumen monolithic shaft
US9132259B2 (en) 2012-11-19 2015-09-15 Abbott Cardiovascular Systems Inc. Multilayer balloon for a catheter
EP3165198A4 (en) * 2014-07-01 2018-01-03 Terumo Kabushiki Kaisha Stent system and method for manufacturing same
WO2016118923A1 (en) * 2015-01-22 2016-07-28 Intersect Ent, Inc. Drug-coated balloon
US11742186B2 (en) * 2017-05-21 2023-08-29 Jiangsu Favored Nanotechnology Co., LTD Multi-functional protective coating

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4948628A (en) 1988-07-01 1990-08-14 Becton, Dickinson And Company Method for plasma treatment of small diameter tubes
US5804263A (en) 1990-10-24 1998-09-08 University Of Florida Research Foundation, Inc. Combined plasma and gamma radiation polymerization method for modifying surfaces
EP0519087B1 (en) 1991-05-21 1997-04-23 Hewlett-Packard GmbH Method for pretreating the surface of a medical device
US5569221A (en) 1994-07-07 1996-10-29 Ep Technologies, Inc. Catheter component bond and method
US6017577A (en) 1995-02-01 2000-01-25 Schneider (Usa) Inc. Slippery, tenaciously adhering hydrophilic polyurethane hydrogel coatings, coated polymer substrate materials, and coated medical devices
US5919570A (en) 1995-02-01 1999-07-06 Schneider Inc. Slippery, tenaciously adhering hydrogel coatings containing a polyurethane-urea polymer hydrogel commingled with a poly(N-vinylpyrrolidone) polymer hydrogel, coated polymer and metal substrate materials, and coated medical devices
US5662960A (en) 1995-02-01 1997-09-02 Schneider (Usa) Inc. Process for producing slippery, tenaciously adhering hydrogel coatings containing a polyurethane-urea polymer hydrogel commingled with a poly (n-vinylpyrrolidone) polymer hydrogel
MX9705922A (en) 1995-02-01 1997-10-31 Schneider Usa Inc Process for hydrophilicization of hydrophobic polymers.
US5576072A (en) 1995-02-01 1996-11-19 Schneider (Usa), Inc. Process for producing slippery, tenaciously adhering hydrogel coatings containing a polyurethane-urea polymer hydrogel commingled with at least one other, dissimilar polymer hydrogel
US5932299A (en) 1996-04-23 1999-08-03 Katoot; Mohammad W. Method for modifying the surface of an object
US6174329B1 (en) 1996-08-22 2001-01-16 Advanced Cardiovascular Systems, Inc. Protective coating for a stent with intermediate radiopaque coating
US6495624B1 (en) 1997-02-03 2002-12-17 Cytonix Corporation Hydrophobic coating compositions, articles coated with said compositions, and processes for manufacturing same
US6013054A (en) 1997-04-28 2000-01-11 Advanced Cardiovascular Systems, Inc. Multifurcated balloon catheter
FR2766092B1 (en) 1997-07-16 1999-10-08 Centre Nat Rech Scient IMPLANTABLE DEVICE COATED WITH A POLYMER CAPABLE OF RELEASING BIOLOGICALLY ACTIVE SUBSTANCES
US6306166B1 (en) 1997-08-13 2001-10-23 Scimed Life Systems, Inc. Loading and release of water-insoluble drugs
CA2298543A1 (en) * 1997-08-13 1999-02-25 James Barry Loading and release of water-insoluble drugs
GB9726807D0 (en) 1997-12-18 1998-02-18 Mupor Ltd Hydrophobic/Oleophobic surfaces and a method of manufacture
US6299596B1 (en) 1998-03-20 2001-10-09 Schneider (Usa) Inc. Method of bonding polymers and medical devices comprising materials bonded by said method
EP1100860A1 (en) 1998-07-29 2001-05-23 The Procter & Gamble Company Detergent composition having a plasma-induced, water-soluble coating and process for making same
US6335029B1 (en) * 1998-08-28 2002-01-01 Scimed Life Systems, Inc. Polymeric coatings for controlled delivery of active agents
US6613432B2 (en) 1999-12-22 2003-09-02 Biosurface Engineering Technologies, Inc. Plasma-deposited coatings, devices and methods
US7947059B2 (en) 2000-03-02 2011-05-24 Boston Scientific Scimed, Inc. Multilayer medical device
US20020111590A1 (en) 2000-09-29 2002-08-15 Davila Luis A. Medical devices, drug coatings and methods for maintaining the drug coatings thereon
US7396582B2 (en) 2001-04-06 2008-07-08 Advanced Cardiovascular Systems, Inc. Medical device chemically modified by plasma polymerization
US6946173B2 (en) * 2002-03-21 2005-09-20 Advanced Cardiovascular Systems, Inc. Catheter balloon formed of ePTFE and a diene polymer
US6939321B2 (en) * 2002-09-26 2005-09-06 Advanced Cardiovascular Systems, Inc. Catheter balloon having improved balloon bonding

Also Published As

Publication number Publication date
US7335185B2 (en) 2008-02-26
EP1648535B1 (en) 2012-07-04
US20050015105A1 (en) 2005-01-20
EP1648535A1 (en) 2006-04-26
JP4740843B2 (en) 2011-08-03
WO2005014075A1 (en) 2005-02-17
JP2007518449A (en) 2007-07-12

Similar Documents

Publication Publication Date Title
US7335185B2 (en) Protective coatings for medical devices
US20230144850A1 (en) Controlled porosity devices for tissue treatments, methods of use, and methods of manufacture
US7951413B2 (en) Catheter balloon having a lubricious coating
US7635510B2 (en) High performance balloon catheter/component
EP1807020B1 (en) Medical devices coated with diamond-like carbon
AU676808B2 (en) Lubricious flow directed catheter
EP1986710B1 (en) Medical balloons
EP2063924B1 (en) Medical balloons with modified surfaces
EP2015817B1 (en) New high pressure balloon
KR20140074378A (en) Balloon assemblies having controllably variable topographies
JPH07504599A (en) lubricious catheter
JP2010500111A (en) Inflatable donut shaped balloon
JPH06296693A (en) Production of catheter for expanding blood vessel

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued

Effective date: 20130528